May 9 (SeeNews) - Croatian drug maker Pliva, a subsidiary of U.S. pharmaceuticals producer Barr, reported on Friday a first-quarter net profit of 28.7 million kuna ($6.1 million/4.0 million euro), down from 374 million kuna a year earlier.